Preparation method and application of treatment-grade mesenchymal stem cells based on induced pluripotent stem cells
A stem cell and cell technology, applied in the fields of biomedicine and biology, can solve the problems of complicated operation, unstable quality, small output, etc., and achieve the effects of high efficiency, simple operation and short culture period.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0041] Example 1 Establishment of the method for preparing MSCs derived from human iPSCs
[0042] 1. Culture of human-derived iPSCs
[0043] We use TeSR that is xeno-free from animal source components TM -E8 TM (STEMCELL Technologies, Catalog#5990) human ESC / iPSC medium, cultured human iPSCs in a feeder-free culture mode (take normal human skin fibroblasts, see references Warren L, Ni Y, Wang J, Guo X. Feeder-free derivation of human induced pluripotent stem cells with messenger RNA. Sci Rep.2012; 2: 657. doi: 10.1038 / srep00657. Epub 2012 Sep 14. Acquired by the method of cultivation), the culture conditions are 37 ° C, 5% -10% o 2 and 10%-15% CO 2 , 95% humidity. Change fluid daily.
[0044] For the typical morphology of iPSCs maintained in culture, see figure 1 . The typical morphology of iPSCs, the clonal cells are aggregated in a round shape with uniform shape and neat edges. Photographed under a microscope at 100×.
[0045] 2. Induction medium combination A susp...
Embodiment 2
[0051] 1. Culture of human-derived iPSCs
[0052] With embodiment 1.
[0053] 2.1. Induction medium combination A Suspension culture induces iPSCs-EB differentiation
[0054] Induction medium combination A is: ①TeSR TM -E8 TM Human ESC / iPSC medium; ② CHIR-99021 (CT99021), the final concentrations are 1 μM, 25 μM and 50 μM; ③ human serum (allogeneic source), the final concentrations are set to 1%, 10% and 20% (volume percentage); ④ Fatty acid mixture (volume ratio 1:1000, Sigma, L0288), 1× non-essential amino acid solution (NEAA, Gibco, 11140-050), human fibroblast growth factor (bFGF, R&D, 233-FB-01M, 1-50ng / mL can be used, 20ng / mL is used in this implementation case), vitamin C (Vc, Sigma, A4403, 1-10 μM is all available, 2 μM is used in this implementation case). All the other are with embodiment 1.
[0055] 2.2. Receive MSCs
[0056] With embodiment 1.
Embodiment 3
[0058] 1. Culture of human-derived iPSCs
[0059] With embodiment 1.
[0060] 2.1. Induction medium combination A Suspension culture induces iPSCs-EB differentiation
[0061] Induction medium combination A is: ①TeSR TM -E8 TM Human ESC / iPSC medium; ② CHIR-99021 (CT99021), the final concentrations were 1 μM, 25 μM and 50 μM; ③ Fetal bovine serum, the final concentrations were set to 1%, 10% and 20% respectively; ④ Fatty acid mixture (vol. Ratio 1:1000, Sigma, L0288), 1× non-essential amino acid solution (NEAA, Gibco, 11140-050), human fibroblast growth factor (bFGF, R&D, 233-FB-01M, 1-50ng / mL can be , this implementation case selects 20ng / mL), vitamin C (Vc, Sigma, A4403, 1-10 μ M can be selected, and this implementation case selects 2 μ M). All the other are with embodiment 1.
[0062] 2.2. Receive MSCs
[0063] With embodiment 1.
PUM
Property | Measurement | Unit |
---|---|---|
thickness | aaaaa | aaaaa |
thickness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com